Camille Dumentat v. HHS - Influenza, Guillain-Barré Syndrome (GBS) (2022)

Camille Dumentat filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging she suffered Guillain-Barré Syndrome (GBS) after receiving an influenza vaccine on October 10, 2019. The case was assigned to the Special Processing Unit.

Respondent filed a Rule 4(c) report conceding that Petitioner is entitled to compensation, as her condition meets the Table definition for GBS. A ruling on entitlement was issued on February 24, 2022, finding Petitioner entitled to compensation.

Subsequently, on November 3, 2022, Respondent filed a proffer on award of compensation, recommending an award of $173,443.39. This amount includes $155,000.00 for pain and suffering and $18,443.39 for past and future unreimbursable expenses.

Petitioner, identified as a competent adult, agreed with the proffered award. The Chief Special Master issued a decision awarding Petitioner the lump sum of $173,443.39.